Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

Search Results for: COVID-19

IVD Firms Report Strong Growth Because of COVID-19 Testing

TO NO ONE’S SURPRISE, THOSE IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS that produce molecular tests, instruments, and automation used for COVID-19 testing reported strong growth in revenue and profits during 2020.  In recent weeks, these companies issued their earnings reports for the fourth quarter 2020 and full year 2020. As expected, most companies announced substantial increases […]

To access this post, you must purchase The Dark Report.

IVD Firms Report Strong Growth Because of COVID-19 Testing Read More »

Despite COVID-19, Regular Lab Testing Expands

TIMES ARE GOOD FOR THE REGULAR RANGE of clinical laboratory and anatomic pathology testing services. Despite the COVID-19 pandemic, the daily number of routine test specimens is near pre-pandemic levels and certain sectors of lab testing—particularly genetic tests and some high-cost assays—are showing substantial growth this year, compared to 2019.  It may surprise many clinical

To access this post, you must purchase The Dark Report.

Despite COVID-19, Regular Lab Testing Expands Read More »

What Comes Next? Predictions on COVID-19 Test Volumes in 2021-22

CEO SUMMARY: Incoming data show that the number of referrals for both COVID-19 tests and routine tests is in a decline that started in October and is continuing. This complicates the strategic planning for hospital/health system labs, independent labs, and pathology groups. They need to make accurate predictions about the demand for tests in coming

To access this post, you must purchase The Dark Report.

What Comes Next? Predictions on COVID-19 Test Volumes in 2021-22 Read More »

COVID-19 Variant Sequencing Offers Clinical Opportunities

This is an excerpt of a 2,987-word article in the March 1, 2021 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: In Wisconsin, an oncology research lab started sequencing variants of the SARS-CoV-2 virus and found multiple uses for such test results to

To access this post, you must purchase The Dark Report.

COVID-19 Variant Sequencing Offers Clinical Opportunities Read More »

Pathology Lab Transforms, Runs 1M COVID-19 Tests

CEO SUMMARY: Last spring, a histopathology lab in Illinois began running molecular COVID-19 tests and decided the clinical side of the lab would focus exclusively on PCR testing for COVID-19. The challenge was how to access a reliable source of test kits, reagents, and supplies to operate 24 hours a day, seven days a week.

To access this post, you must purchase The Dark Report.

Pathology Lab Transforms, Runs 1M COVID-19 Tests Read More »

Digital Pathology Launched in the ‘Era of COVID-19’

CEO SUMMARY: Is it smart to initiate digital pathology (DP) systems and whole-slide imaging just as a novel coronavirus upends healthcare and society at large? That was the question asked at Poplar Healthcare, a pathology lab in Memphis. Senior management proceeded with the implementation, despite the uncertainty that accompanied the SARS-CoV-2 pandemic. Nine months later,

To access this post, you must purchase The Dark Report.

Digital Pathology Launched in the ‘Era of COVID-19’ Read More »

Top 10 2020 Lab Stories Are about More than Just COVID-19

This is an excerpt of a 3,689-word article in the December 28, 2020 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: There are several surprises in The Dark Report’s list of the Top 10 Lab Stories for 2020. Despite the SARS-CoV-2 pandemic dominating

To access this post, you must purchase The Dark Report.

Top 10 2020 Lab Stories Are about More than Just COVID-19 Read More »

NorDx Lab Started to Prepare for COVID-19 Testing in 2019

CEO SUMMARY: In a remarkable example of prescience, informed by decades-long experience in clinical lab testing and past epidemics, the president of NorDx Laboratories in Maine saw the December news accounts of a widespread outbreak of a new respiratory disease in China. He warned his lab team to assume the worst and energized them to

To access this post, you must purchase The Dark Report.

NorDx Lab Started to Prepare for COVID-19 Testing in 2019 Read More »

COVID-19 or Not, Lab Market Enters ‘Twilight Zone’

Our healthcare system is in a most remarkable state. Even as all providers—including clinical laboratories and anatomic pathology groups—continue to devote considerable resources to meeting the urgent need for SARS-CoV-2 testing, health insurers and regulators continue to issue new requirements governing all aspects of “normal” lab testing activities.  Today, all clinical labs and pathology groups

To access this post, you must purchase The Dark Report.

COVID-19 or Not, Lab Market Enters ‘Twilight Zone’ Read More »

NY Hospital Lab Succeeds with Pooled COVID-19 Testing

CEO SUMMARY: Pooled testing helps the clinical lab staff at the hospital in Saratoga Springs, N.Y., do more COVID-19 tests when supplies might otherwise run short. Lab managers estimate this method has saved 5,000 test cartridges since May. Pooled testing also helps the physician staff in the emergency department identify patients who may be positive

To access this post, you must purchase The Dark Report.

NY Hospital Lab Succeeds with Pooled COVID-19 Testing Read More »

;